Programme at a glance

Programme at a glance, London

Thursday, 26 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
17.45 - 18.45
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis
17.45
Best clinical papers published in 2020
‣ René Rizzoli
18.30
Opening of the meeting
‣ Cyrus Cooper
18.35
Presentation of the 2020 ESCEO Medal of Excellence
18.40
Presentation of the IOF Olof Johnell Science Award
Friday, 27 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: ‣ Cyrus Cooper, ‣ Jean‑Yves Reginster
09.00
Plenary Lecture 1
‣ Management of musculoskeletal disease from cradle to grave Cyrus Cooper
09.30
Oral communication selected from abstracts
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: ‣ John A. Kanis, ‣ René Rizzoli
10.30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
10.35
Presentation of the IOF President's Award
10.40
Plenary Lecture 2
‣ Building bone strength with anabolic agents Michael R. McClung
11.10
Oral communication selected from abstracts
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Transgender medicine, bone and muscle
‣ Jean‑Marc Kaufman
Impact of glucocorticoids on bone and muscle
‣ Evelien Gielen
HIV and bone
‣ Emmanuel Biver
Is screening of osteoporosis useful?
‣ E. M. Curtis
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.10
Oral presentation of selected posters
14.00 - 15.00
Educational Lecture
‣ Dietary patterns and fracture risk Stefania Maggi
14.00 - 15.00
ESCEO Symposium
‣ Determinants of the differences between the ESCEO and OARSI 2019 guidelines for the management of knee osteoarthritis
Chairpersons: ‣ Ali Mobasheri, ‣ Jean‑Yves Reginster
‣ Similarities and differences between the OARSI and ESCEO guidelines for the management of knee osteoarthritis Tim McAlindon
‣ How can we explain the differences between the OARSI and ESCEO guidelines for the management of knee osteoarthritis? Nigel K. Arden
‣ Discussion (Leader: Olivier Bruyère) All
14.00 - 15.00
Update of the ESCEO recommendations for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia
Chairpersons: ‣ Charlotte Beaudart, ‣ Roger A. Fielding
‣ Introduction Alfonso Cruz Jentoft
‣ Patients to be included in clinical trials assessing the safety and efficacy of new chemical entities aiming at the treatment of sarcopenia Mario Miguel Rosa
‣ Primary and secondary endpoints for clinical trials assessing the safety and efficacy of new chemical entities aiming at the treatment of sarcopenia Andrea Laslop
‣ Discussion (Leader : Andrea Trombetti): All participants of the Working Group
‣ Conclusion Jürgen Bauer
14.00 - 15.00
Educational Lecture (supported by an unrestricted grant from IBSA)
‣ Meet the evidence of pharma-grade chondroitin sulfate Nicola Veronese
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: ‣ Radmila Matijevic, ‣ Manju Chandran
15.00
Plenary Lecture 3
‣ Management of bone disease in cancer Robert E. Coleman
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
‣ Thyroid, bone and cartilage G Williams
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
15.45
Presentation of the IOF Committee of National Societies Medal
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Saturday, 28 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESCEO-IOF Working Group
‣ Role of orthopaedic surgeons to ensure optimal Vitamin D levels in patients operated for an osteoporotic fracture
Chairpersons: ‣ Didier Hannouche, ‣ Gerrit Maier
‣ Introduction and scope of the problem René Rizzoli
‣ Prevalence of Vitamin D sufficiency/deficiency in patients admitted to the orthopaedic ward Nicholas Harvey
‣ Benefits of Vitamin D in patients with fragility fracture Kyriakos Papavasiliou
‣ Supplementation with Vitamin D during rehabilitation Giovanni Iolascon
‣ Discussion (Leader: Maria Luisa Brandi): All participants of the Working Group
‣ Closure of the meeting
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: ‣ Evelien Gielen, ‣ Bess Dawson‑Hughes
09.00
Plenary Lecture 5
‣ Bone and cartilage talk together Ali Mobasheri
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10.30 - 12.10
SCIENTIFIC SESSION V
Chairpersons: ‣ Elaine M. Dennison, ‣ Maria Luisa Brandi
10.30
Presentation of the IOF Medal of Achievement
10.40
Plenary Lecture 6
‣ Are there treatments for sarcopenia? Marjolein Visser
11.10
Oral communication selected from abstracts
12.15 - 13.45
AVAILABLE INDUSTRY SATELLITE LUNCH SYMPOSIUM
12.15 - 13.45
AVAILABLE INDUSTRY SATELLITE LUNCH SYMPOSIUM
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Calcium-vitamin D, still a role in osteoporosis management?
‣ Elaine M. Dennison
Discussion of complex bone disorder cases
‣ Nicholas R. Fuggle
Fracture during childhood and adolescence

Rehabilitation after fragility fracture
‣ Olivier Bruyère
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.10
Oral presentation of selected posters
14.00 - 15.00
Educational Lecture
‣ Peak bone mass and primary fracture prevention Peter R. Ebeling
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: ‣ Charlotte Beaudart, ‣ Claudia Campusano
15.00
Plenary Lecture 7
‣ Gut microbiome, bone and joint G Schett
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 8
‣ Rehabilitation of menopausal hormone therapy in osteoporosis management I Lambrinoudaki
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Sunday, 29 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESCEO-IOF-SICOT joint Symposium : Fracture Liaison Services (FLS) in Orthopaedic Surgery
Chairpersons: ‣ Josée Delisle, ‣ Philippe Halbout
‣ Opening message Philippe Halbout, Josée Delisle
‣ Success story of collaboration between orthopaedics and rest of the world in FLS! How can I work with my orthopaedic surgeon? Julio Fernandes
‣ Getting FLSs sustainable- key steps Kassim Javaid
‣ Teams and empowerment! How to create synergy between the Nurse, Doctor, Family and the Patient? Josée Delisle
‣ Crossfire and Q&A
‣ Closing message Josée Delisle
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Can we influence fracture repair?
‣ Julio Fernandes
FLS and fracture risk reduction
‣ Kassim Javaid
How to warrant reliable data for calciotropic hormones and bone turnover markers assays
‣ Etienne Cavalier
Management of men with osteoporosis
‣ Alberto Ferlin
09.00 - 10.00
Poster Viewing Session III
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: ‣ Stefania Maggi, ‣ Gemma Adib
10.00
Plenary Lecture 9
‣ Is genetics helping to improve osteoporosis management ? E Duncan
10.30
Presentation of the ESCEO-IOF Young Investigator Awards
10.40
Oral communication selected from abstracts
11.40
Plenary Lecture 10
‣ New approaches of rare skeletal diseases management Maria Luisa Brandi
12.00 - 13.00
NON-SPONSORED SYMPOSIA